USNA

$13.777.40%-1.10

Dopo l'orario di chiusura: 13.80+0.03 +0.22%

Usana Health Sciences Inc (USNA)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$14.87

Aprire:

$12.69

Volume 24 ore:

92,022

Volume relativo:

0.49

Capitalizzazione di mercato:

$254.42M

Reddito:

$925.94M

Utile/perdita netta:

$9.15M

Rapporto P/E:

28.96

EPS:

$0.4755

Flusso di cassa netto:

$2.96M

1W Prestazione:

-5.81%

1M Prestazione:

-7.09%

6M Prestazione:

-25.81%

1Y Prestazione:

-32.99%

Intervallo 1D:

$12.68$14.39

Intervallo di 1 settimana:

$12.68$15.21

Portata 52W:

$12.57$23.59

Profilo aziendale di Usana Health Sciences Inc (USNA)

Nome

Usana Health Sciences Inc

Settore

Consumer Defensive

Industria

Packaged Foods

Telefono

(801) 954-7100

Indirizzo

3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, USA

Dipendente

1,570

@USANAinc

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di USNA su X

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Usana Health Sciences Inc Azioni (USNA) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2023-06-23	Iniziato	Sidoti	Buy
2022-07-07	Downgrade	Jefferies	Hold → Underperform
2022-04-14	Iniziato	DA Davidson	Neutral
2020-12-17	Iniziato	ROTH Capital	Buy
2019-08-22	Iniziato	Jefferies	Hold
2019-04-16	Iniziato	Tigress Financial	Buy
2018-10-25	Aggiornamento	Sidoti	Neutral → Buy
2018-10-24	Aggiornamento	Pivotal Research Group	Hold → Buy
2018-04-23	Downgrade	Pivotal Research Group	Buy → Hold
2018-02-07	Reiterato	Pivotal Research Group	Buy
2018-01-24	Downgrade	Sidoti	Buy → Neutral
2017-10-25	Reiterato	Pivotal Research Group	Buy
2017-07-26	Reiterato	Pivotal Research Group	Buy
2017-05-03	Aggiornamento	Pivotal Research Group	Hold → Buy
2017-05-01	Downgrade	Pivotal Research Group	Buy → Hold
2017-02-08	Reiterato	Pivotal Research Group	Buy
2016-07-28	Reiterato	DA Davidson	Neutral
2016-02-10	Downgrade	DA Davidson	Buy → Neutral
2015-10-16	Aggiornamento	Sidoti	Neutral → Buy
2015-09-16	Aggiornamento	DA Davidson	Neutral → Buy
2015-08-06	Downgrade	DA Davidson	Buy → Neutral
2015-08-05	Aggiornamento	Pivotal Research Group	Hold → Buy
2015-06-26	Iniziato	DA Davidson	Buy

Usana Health Sciences Inc Azioni (USNA) Dati Finanziari

Periodo	FY 2025	FY 2023	FY 2022	FY 2020	FY 2019
Data di fine periodo	2026-01-03	2024-12-28	2022-12-31	2021-01-02	2019-12-28
Revenue USD (M)	925.26	921.01	1,186.46	1,134.64	1,060.90
Cost of revenue USD (M)	200.85	176.69	217.90	209.11	187.50
Gross profit USD (M)	724.41	744.32	968.57	925.53	873.40
Research and development USD (M)	10.69	11.45	11.11	10.63	10.26
Operating expenses USD (M)	686.97	651.25	798.37	749.04	727.21
Operating income USD (M)	37.43	93.07	170.19	176.49	146.19
Income before tax USD (M)	41.53	102.45	170.64	177.95	150.50
Income tax expense USD (M)	30.05	38.67	54.14	53.28	49.97
Net income USD (M)	11.48	63.79	116.51	124.66	100.53
Basic EPS USD/shares	0.58	3.31	5.78	5.89	4.44
Diluted EPS USD/shares	0.58	3.30	5.73	5.86	4.41
Basic weighted shares shares (M)	18.54	19.25	20.15	21.16	22.64
Diluted weighted shares shares (M)	18.57	19.35	20.34	21.26	22.82
Selling, general and administrative USD (M)	337.37	256.99	279.11	261.19	267.73

Usana Health Sciences Inc Azioni (USNA) insider trading

BRENT LOWELL NEIDIGJun 16 '26
Officer
Transazione
Proposed Sale
Costo
$19.45
#Azioni
5,002
Valore ($)
97,304
#Azioni Totale
0
Neidig BrentJun 16 '26
CHIEF COMMERCIAL OFFICER
Transazione
Sale
Costo
$19.45
#Azioni
5,002
Valore ($)
97,304
#Azioni Totale
0
Neidig BrentJun 15 '26
CHIEF COMMERCIAL OFFICER
Transazione
Sale
Costo
$20.00
#Azioni
909
Valore ($)
18,185
#Azioni Totale
5,002
BRENT LOWELL NEIDIGJun 15 '26
Officer
Transazione
Proposed Sale
Costo
$20.01
#Azioni
909
Valore ($)
18,185
#Azioni Totale
0
Neidig BrentJun 12 '26
CHIEF COMMERCIAL OFFICER
Transazione
Sale
Costo
$20.15
#Azioni
1,602
Valore ($)
32,280
#Azioni Totale
5,911
PAUL A JONESJun 08 '26
Officer
Transazione
Proposed Sale
Costo
$18.50
#Azioni
5,561
Valore ($)
102,878
#Azioni Totale
0
Jones Paul A.Jun 08 '26
CHIEF PEOPLE OFFICER
Transazione
Sale
Costo
$18.50
#Azioni
5,561
Valore ($)
102,878
#Azioni Totale
0
Fleming John TurmanJun 01 '26
Director
Transazione
Sale
Costo
$17.93
#Azioni
2,450
Valore ($)
43,928
#Azioni Totale
4,230
Jones Paul A.May 28 '26
CHIEF PEOPLE OFFICER
Transazione
Sale
Costo
$18.95
#Azioni
6,813
Valore ($)
129,106
#Azioni Totale
5,561
PAUL A JONESMay 28 '26
Officer
Transazione
Proposed Sale
Costo
$18.95
#Azioni
6,813
Valore ($)
129,106
#Azioni Totale
0

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
BRENT LOWELL NEIDIG	Officer	Jun 16 '26	Proposed Sale	$19.45	5,002	97,304	0
Neidig Brent	CHIEF COMMERCIAL OFFICER	Jun 16 '26	Sale	$19.45	5,002	97,304	0
Neidig Brent	CHIEF COMMERCIAL OFFICER	Jun 15 '26	Sale	$20.00	909	18,185	5,002
BRENT LOWELL NEIDIG	Officer	Jun 15 '26	Proposed Sale	$20.01	909	18,185	0
Neidig Brent	CHIEF COMMERCIAL OFFICER	Jun 12 '26	Sale	$20.15	1,602	32,280	5,911
PAUL A JONES	Officer	Jun 08 '26	Proposed Sale	$18.50	5,561	102,878	0
Jones Paul A.	CHIEF PEOPLE OFFICER	Jun 08 '26	Sale	$18.50	5,561	102,878	0
Fleming John Turman	Director	Jun 01 '26	Sale	$17.93	2,450	43,928	4,230
Jones Paul A.	CHIEF PEOPLE OFFICER	May 28 '26	Sale	$18.95	6,813	129,106	5,561
PAUL A JONES	Officer	May 28 '26	Proposed Sale	$18.95	6,813	129,106	0

Usana Health Sciences Inc Borsa (USNA) Ultime notizie

Nov 03, 2026

USANA Health Sciences (USNA) Reports Q3 Loss, Lags Revenue Estimates - Zacks Investment Research

Nov 03, 2026

Oct 27, 2026

USANA Health Sciences (USNA) Set to Release Quarterly Earnings on Tuesday - MarketBeat

Oct 27, 2026

Oct 24, 2026

Form 4 USANA Health Sciences Inc: Frederic J. Winssinger (Director) For: 22 October - Investing.com Nigeria

Oct 24, 2026

USANA Health Sciences, Inc. Estimates – NYSE:USNA - TradingView

Oct 24, 2026

Oct 23, 2026

After acquiring 1,632 shares, USANA (USNA) director Fuller holds 3,264 common shares. - Stock Titan

Oct 23, 2026

Oct 21, 2026

Dennis Fantoni - etoro Popular Investor | Strategy & Performance - eToro

Oct 21, 2026

Oct 20, 2026

China unites modern nutritional science with traditional medicine - NUFFOODS Spectrum ASIA

Oct 20, 2026

Zacks upgrades USANA Health Sciences stock from strong sell to hold - ad-hoc-news.de

Oct 20, 2026

Oct 18, 2026

USANA schedules third-quarter results for USANA Health Sciences stock - ad-hoc-news.de

Oct 18, 2026

Oct 15, 2026

USANA sets November 3 results date for USANA Health Sciences stock - ad-hoc-news.de

Oct 15, 2026

Oct 13, 2026

A Look at Usana Health Sciences Inc (USNA) After 3.4% Gain -- GF Value $35.54 vs Price $15.46 - GuruFocus

Oct 13, 2026

Oct 12, 2026

USANA Schedules Third Quarter 2026 Earnings Release and Conference Call - Business Wire

Oct 12, 2026

Oct 10, 2026

How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing - Stock Traders Daily

Oct 10, 2026

How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing - Stock Traders Daily

Oct 10, 2026

Oct 07, 2026

USANA Health Sciences (NYSE:USNA) Upgraded at Zacks Research - MarketBeat

Oct 07, 2026

USANA Health Sciences and University of Utah Athletics Announce New Partnership - PR Newswire

Oct 07, 2026

USANA Health Sciences and University of Utah Athletics Announce New Partnership - Financial Times

Oct 07, 2026

USANA Health Sciences and University of Utah Athletics Announce New Partnership - Yahoo Finance

Oct 07, 2026

USANA expands Utah partnership: what it means for USANA Health Sciences stock - AD HOC NEWS

Oct 07, 2026

USANA expands Utah partnership: what it means for USANA Health Sciences stock - AD HOC NEWS

Oct 07, 2026

Oct 06, 2026

USANA Health Sciences (NYSE:USNA) Stock Price - Simply Wall Street

Oct 06, 2026

USANA Health Sciences stock reports a Q2 loss before October results - AD HOC NEWS

Oct 06, 2026

Oct 05, 2026

USANA Health Sciences, Inc. Enters into First Amendment to Third Amended and Restated Credit Agreement - www.marketscreener.com

Oct 05, 2026

The annual general asset-sale limit rises to $2.5M in book value under USANA (USNA)'s credit amendment. - Stock Titan

Oct 05, 2026

USANA Health Sciences stock costs EUR 13.20 ahead of results - AD HOC NEWS

Oct 05, 2026

Oct 01, 2026